Amalgamated Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,770
| Closed | -$195K | – | 3020 |
|
|
2024
Q2 | $195K | Buy |
4,770
+2,385
| +100% | +$97.5K | ﹤0.01% | 1585 |
|
|
2024
Q1 | $101K | Sell |
2,385
-7,642
| -76% | -$324K | ﹤0.01% | 1720 |
|
|
2023
Q4 | $425K | Buy |
10,027
+809
| +9% | +$34.3K | ﹤0.01% | 1503 |
|
|
2023
Q3 | $201K | Hold |
9,218
| – | – | ﹤0.01% | 1789 |
|
|
2023
Q2 | $293K | Buy |
9,218
+1,122
| +14% | +$35.7K | ﹤0.01% | 1679 |
|
|
2023
Q1 | $197K | Sell |
8,096
-1,462
| -15% | -$35.6K | ﹤0.01% | 1811 |
|
|
2022
Q4 | $301K | Buy |
9,558
+834
| +10% | +$26.3K | ﹤0.01% | 1696 |
|
|
2022
Q3 | $247K | Buy |
8,724
+138
| +2% | +$3.91K | ﹤0.01% | 1779 |
|
|
2022
Q2 | $227K | Buy |
8,586
+1,953
| +29% | +$51.6K | ﹤0.01% | 1822 |
|
|
2022
Q1 | $232K | Sell |
6,633
-497
| -7% | -$17.4K | ﹤0.01% | 1886 |
|
|
2021
Q4 | $231K | Buy |
7,130
+11
| +0.2% | +$356 | ﹤0.01% | 1929 |
|
|
2021
Q3 | $210K | Buy |
+7,119
| New | +$210K | ﹤0.01% | 1979 |
|